The Chemours Company (CC) FY2026 YTD Q2 P&L / Income Statement

The Chemours Company (CC) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Statement Geographical by Timing Of Transfer Of Good Or Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

2,972,000,000 US dollars

Cost of goods sold

2,474,000,000 US dollars

Gross profit

498,000,000 US dollars

Total other operating expenses

685,000,000 US dollars

Operating profit (calculated)

negative 187,000,000 US dollars

Other income (expense), net (calculated)

165,000,000 US dollars

Loss before income taxes

negative 22,000,000 US dollars

Provision for income taxes

281,000,000 US dollars

Net loss

negative 303,000,000 US dollars

Asia Pacific - Transferred at a Point in Time

555,000,000 US dollars

Latin America - Transferred at a Point in Time

385,000,000 US dollars

North America - Transferred at a Point in Time

1,417,000,000 US dollars

Europe, the Middle East, and Africa - Transferred at a Point in Time

615,000,000 US dollars

Selling, general, and administrative expense

616,000,000 US dollars

Research and development expense

53,000,000 US dollars

Restructuring, asset-related, and other charges

16,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.